Hap Trading, LLC Biomarin Pharmaceutical Inc Transaction History

Hap Trading, LLC

$935 Billion
Q1 2025

A detailed history of Hap Trading, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Hap Trading, LLC holds 11,634 shares of BMRN stock, worth $691,757. This represents 0.09% of its overall portfolio holdings.

Number of Shares

11,634

Previous 13,845 15.97%

Holding current value

$691,757

Previous $910 Million 9.63%

% of portfolio

0.09%

Previous 0.08%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$61.25 - $72.83 $135,423 - $161,027	-2,211 Reduced 15.97%	11,634 $822 Million
Q4 2024 Feb 13, 2025	SELL	$61.93 - $70.49 $552,477 - $628,841	-8,921 Reduced 39.19%	13,845 $910 Million
Q3 2024 Nov 12, 2024	SELL	$69.02 - $93.84 $878,417 - $1.19 Million	-12,727 Reduced 35.86%	22,766 $1.6 Billion
Q2 2024 Aug 14, 2024	BUY	$74.43 - $92.22 $2.64 Million - $3.27 Million	35,493 New	35,493 $2.92 Billion
Q1 2022 May 12, 2022	SELL	$74.28 - $92.69 $1.47 Million - $1.83 Million	-19,749 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$71.72 - $91.47 $232,803 - $296,911	3,246 Added 19.67%	19,749 $1.75 Million
Q3 2021 Nov 10, 2021	SELL	$74.77 - $85.47 $58,171 - $66,495	-778 Reduced 4.5%	16,503 $1.28 Million
Q2 2021 Aug 11, 2021	BUY	$75.51 - $84.79 $196,326 - $220,454	2,600 Added 17.71%	17,281 $1.44 Million
Q1 2021 May 14, 2021	SELL	$74.73 - $90.69 $326,644 - $396,405	-4,371 Reduced 22.94%	14,681 $1.11 Million
Q4 2020 Feb 16, 2021	SELL	$72.61 - $90.2 $248,180 - $308,303	-3,418 Reduced 15.21%	19,052 $1.67 Million
Q3 2020 Nov 13, 2020	BUY	$71.87 - $131.03 $1.61 Million - $2.94 Million	22,470 New	22,470 $1.71 Million
Q3 2019 Nov 12, 2019	SELL	$67.4 - $85.11 $926,008 - $1.17 Million	-13,739 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$80.35 - $93.9 $3.14 Million - $3.67 Million	-39,131 Reduced 74.01%	13,739 $1.18 Million
Q3 2018 Nov 09, 2018	SELL	$93.92 - $105.72 $2.57 Million - $2.89 Million	-27,352 Reduced 34.1%	52,870 $5.13 Million
Q2 2018 Aug 13, 2018	BUY	$76.01 - $99.03 $6.1 Million - $7.94 Million	80,222 New	80,222 $7.56 Million
Q1 2018 May 11, 2018	SELL	$77.67 - $92.63 $1.52 Million - $1.81 Million	-19,511 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$80.76 - $95.13 $1.58 Million - $1.86 Million	19,511	19,511 $1.74 Million

Others Institutions Holding BMRN

# of Institutions

666

Shares Held

186M

Call Options Held

1.25M

Put Options Held

992K

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $11B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.

Account